NOTEN (Alphapharm Pty Ltd)
Product name
NOTEN
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
70 working days (255)
Active ingredients
atenolol
Registration type
EOI
Indication
Generic medicine
NOTEN (tablets) is now also indicated for the management of Cardiac arrhythmias (acute treatment of supraventricular and ventricular arrhythmias including those associated with acute myocardial infarction.